Every time Peter Cook speaks, shareholders are fed limited...

Every time Peter Cook speaks, shareholders are fed limited truth. Peter said (QUOTE) “The share buyback was temporarily halted when the company become aware of impending licensing deals and important clinical trial updates”. It will be really strange for Biota not to be constantly discussing potential licensing deals – this is the norm. Important clinical updates? Is it not true that clinical trials are ongoing and updates are given as and when results from the trials are concluded. “Important clinical updates” were also released in the midst earlier buy backs.So what has changed?

What is MOST IMPORTANT why did Peter Cook not announced the suspension in mid-May but waited until end of August? As a matter of fact the company on 30 May announced the number of shares bought back in the 2 weeks in May as for the whole month of May.

In March, they bought back shares as high as $1.29 Without the share buy back, the traded as low as 62cent on 28 July. Was the suspension of buy back a convenient timing for the issuing of shares at zero prices to executives and the issuing of free executive options? 20,350 shares were issued on 30 June and 375,685 shares on 16 July.

The total number of executive options TRIPLED from 578,721 at 30 June 07 to 2,153,418 at 30 June 2008. The 2,153,418 does not include options that expired and options that were converted to free shares in the year.

Why resume buy back now? Is it to provide share price support for the coming AGM? The latest ASX announcement showed that on 20 August, BTA bought more than 55% of the shares turnover on that day driving the price 4.3% up from $0.75 to $0.735 Convenient timing?

Someone please email BTA the above. They are all facts taken from BTA's announcements.